Krishna Institute of Medical Sciences Limited files DRHP with SEBI. Krishna Institute of Medical Sciences Ltd. (the “Company” or “KIMS Hospitals”), one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered, filed its DRHP with SEBI for its proposed initial public offer.
The Company provides multi-disciplinary integrated healthcare services, with a focus on primary, secondary & tertiary care in Tier 2-3 cities and primary, secondary, tertiary and quaternary healthcare in Tier 1 cities.
They operate 9 multi-specialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of December 31, 2020, which is 2.2 times more beds than the second largest provider in AP and Telangana, according to the CRISIL report.
KIMS Hospitals offer a comprehensive range of healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.
The Initial Public Offering comprises of a fresh issue aggregating up to ₹ 2,000.00 million (the “Fresh Issue”) and an offer for sale of up to 21,340,931 equity shares (the “Offer for Sale”), comprising up to 13,977,991 equity shares by General Atlantic Singapore KH Pte. Ltd (the “Investor Selling Shareholder”), up to 775,933 equity shares by Dr. Bhaskara Rao Bollineni, up to 1,163,899 equity shares by Rajyasri Bollineni, up to 387,966 equity shares by Bollineni Ramanaiah Memorial Hospitals Private Limited (collectively, the “Promoter Selling Shareholders”), 5,035,142 equity shares by persons referred to in Annexure A (referred to as the “Other Selling Shareholders”, together with the Investor Selling Shareholder and Promoter Selling Shareholders, the “Selling Shareholders”, and such equity shares the “Offered Shares”). The offer includes a reservation for subscription by eligible employees (the “Employee Reservation Portion”).
The Book Running Lead Managers to the offer are Kotak Mahindra Capital Company Limited, Axis Capital Limited, Credit Suisse Securities (India) Private Limited and IIFL Securities Limited. The equity shares are proposed to be listed on BSE and NSE.